Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Pre-hospital blood transfusion - an ESA survey of European practice

KC. Thies, A. Truhlář, D. Keene, J. Hinkelbein, K. Rützler, L. Brazzi, B. Vivien

. 2020 ; 28 (1) : 79. [pub] 20200814

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21012267

BACKGROUND: Blood products are a lifesaving commodity in the treatment of major trauma. Although there is little evidence for use of pre-hospital blood products (PHBP) in seriously injured patients, an increasing number of emergency medical services have started using PHBP for treatment of major haemorrhage. The primary aim of this survey was to establish the degree of prehospital blood product use throughout Europe and discover main indications. The secondary aim was to evaluate opinions about PHBP and also the experience and the personal views of its users. METHODS: The subcommittee for Critical Emergency Medicine of the European Society of Anaesthesiology (ESA) held an online survey of European Helicopter Emergency Services (HEMS) and all French Services d'Aide Médicale Urgente (SAMU) regions. It contained 13 questions both open and multiple-choice about the frequency transfusions are carried out, the PHBP used and the perceived benefit. The survey was distributed to the corresponding HEMS leads in 14 European countries. RESULTS: In total there were 172 valid responses; overall 48% of all respondents have prehospital access to packed red cells, 22% to fresh plasma and 14% use lyophilised plasma. Besides blood product administration, 94% of all services use tranexamic acid. Sixty five percent of all replies came from French and from German services (37 and 28% respectively). PHBP were mainly used for trauma related emergencies. France has the highest uptake of use of blood products at 89%, whereas the rate in Germany was far lower at 6%. Fifty five percent of the service leads felt that PHBP are beneficial, and even lifesaving in individual cases despite being needed infrequently. CONCLUSIONS: We found remarkable dissimilarities in practice between the different European countries. Even if there is not an absolute consensus amongst providers on the benefit of PHBP, the majority feel they are beneficial. The difference in practice is possibly related to the perceived lack of evidence on prehospital blood transfusion. We suggest to include the use of PHBP in trauma registries in order to consolidate the existing evidence.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012267
003      
CZ-PrNML
005      
20210713125156.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13049-020-00774-1 $2 doi
035    __
$a (PubMed)32795320
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Thies, Karl-Christian $u Dept of Anaesthesiology, Critical Care and Pain Medicine, Greifswald University Medical Centre, Greifswald, Germany. karl.thies@uni-greifswald.de
245    10
$a Pre-hospital blood transfusion - an ESA survey of European practice / $c KC. Thies, A. Truhlář, D. Keene, J. Hinkelbein, K. Rützler, L. Brazzi, B. Vivien
520    9_
$a BACKGROUND: Blood products are a lifesaving commodity in the treatment of major trauma. Although there is little evidence for use of pre-hospital blood products (PHBP) in seriously injured patients, an increasing number of emergency medical services have started using PHBP for treatment of major haemorrhage. The primary aim of this survey was to establish the degree of prehospital blood product use throughout Europe and discover main indications. The secondary aim was to evaluate opinions about PHBP and also the experience and the personal views of its users. METHODS: The subcommittee for Critical Emergency Medicine of the European Society of Anaesthesiology (ESA) held an online survey of European Helicopter Emergency Services (HEMS) and all French Services d'Aide Médicale Urgente (SAMU) regions. It contained 13 questions both open and multiple-choice about the frequency transfusions are carried out, the PHBP used and the perceived benefit. The survey was distributed to the corresponding HEMS leads in 14 European countries. RESULTS: In total there were 172 valid responses; overall 48% of all respondents have prehospital access to packed red cells, 22% to fresh plasma and 14% use lyophilised plasma. Besides blood product administration, 94% of all services use tranexamic acid. Sixty five percent of all replies came from French and from German services (37 and 28% respectively). PHBP were mainly used for trauma related emergencies. France has the highest uptake of use of blood products at 89%, whereas the rate in Germany was far lower at 6%. Fifty five percent of the service leads felt that PHBP are beneficial, and even lifesaving in individual cases despite being needed infrequently. CONCLUSIONS: We found remarkable dissimilarities in practice between the different European countries. Even if there is not an absolute consensus amongst providers on the benefit of PHBP, the majority feel they are beneficial. The difference in practice is possibly related to the perceived lack of evidence on prehospital blood transfusion. We suggest to include the use of PHBP in trauma registries in order to consolidate the existing evidence.
650    _2
$a antifibrinolytika $x aplikace a dávkování $7 D000933
650    _2
$a krevní transfuze $x statistika a číselné údaje $7 D001803
650    _2
$a urgentní zdravotnické služby $x statistika a číselné údaje $7 D004632
650    _2
$a krvácení $x terapie $7 D006470
650    _2
$a lidé $7 D006801
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a kyselina tranexamová $x aplikace a dávkování $7 D014148
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Truhlář, Anatolij $u Emergency Medical Services of the Hradec Kralove Region, Hradec Kralove, Czech Republic ; Department of Anaesthesiology and Intensive Care, Charles University in Prague, Faculty of Medicine, Hradec Kralove, Czech Republic ; University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
700    1_
$a Keene, Damian $u Department of Military Anaesthetics and Critical Care, Royal Centre for Defence Medicine, Birmingham, United Kingdom
700    1_
$a Hinkelbein, Jochen $u Department of Anaesthesiology and Intensive Care Medicine, Medical Faculty and University Hospital of Cologne, Cologne, Germany
700    1_
$a Rützler, Kurt $u Departments of General Anaesthesiology and Outcomes Research, Cleveland Clinic, Anaesthesiology Institute, Cleveland, USA
700    1_
$a Brazzi, Luca $u Department of Surgical Sciences, University of Turin, Turin, Italy ; Italy Department of Anesthesia, Intensive Care and Emergency, Città della Salute e della Scienza' hospital, Turin, Italy ; University of Torino, Turin, Italy
700    1_
$a Vivien, Benoît $u SAMU de Paris, Anaesthesiology and Critical Care Department, Universitary Hospital Necker - Enfants Malades, APHP Centre - University of Paris, Paris, France
773    0_
$w MED00165386 $t Scandinavian journal of trauma, resuscitation and emergency medicine $x 1757-7241 $g Roč. 28, č. 1 (2020), s. 79
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32795320 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210713125154 $b ABA008
999    __
$a ok $b bmc $g 1650602 $s 1132646
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 28 $c 1 $d 79 $e 20200814 $i 1757-7241 $m Scandinavian journal of trauma, resuscitation and emergency medicine $n Scand J Trauma Resusc Emerg Med $x MED00165386
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Archiving options